{"title":"Trends of Minimally Invasive Hysterectomy: Five Years of Experience.","authors":"Abdulrahman Khinkar, Afaf Felemban, Rahaf AlSomali, Norah AlSunayen, Ahmed Felemban, Joud Makki, Ghadeer Aljahdali","doi":"10.1155/ogi/2366445","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> This study aims to investigate the five-year trend of minimally invasive hysterectomy and identify factors associated with increased intraoperative and postoperative complications within the last five years (2017-2021). <b>Methods:</b> A retrospective chart review was performed between March 30th and April 10th, 2022, which included women who underwent total laparoscopic hysterectomy (TLH), laparoscopic subtotal hysterectomy (LSH), laparoscopic-assisted vaginal hysterectomy (LAVH), and robotic-assisted hysterectomy for benign gynecologic conditions, during the period January 2017 to December 2021. <b>Results:</b> There was an increase in the rate of performing minimally invasive hysterectomy procedures from 35 cases (12.5%) in 2017 to 85 cases (30.5%) in 2021. In addition, abnormal uterine bleeding was the most reported indication for minimally invasive hysterectomy (<i>n</i> = 84; 30.1%). Estimated blood loss was a significant predictor for both intraoperative complications (<i>p</i> < 0.001) and postoperative complications (<i>p</i>=0.004). <b>Conclusion:</b> Within the last five years, there has been an increasing trend of minimally invasive hysterectomy procedures at the OB-GYN department in KAMC, Saudi Arabia. And estimated blood loss is a significant predictor of intraoperative and postoperative complications of minimally invasive hysterectomy.</p>","PeriodicalId":19439,"journal":{"name":"Obstetrics and Gynecology International","volume":"2025 ","pages":"2366445"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12178727/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics and Gynecology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/ogi/2366445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study aims to investigate the five-year trend of minimally invasive hysterectomy and identify factors associated with increased intraoperative and postoperative complications within the last five years (2017-2021). Methods: A retrospective chart review was performed between March 30th and April 10th, 2022, which included women who underwent total laparoscopic hysterectomy (TLH), laparoscopic subtotal hysterectomy (LSH), laparoscopic-assisted vaginal hysterectomy (LAVH), and robotic-assisted hysterectomy for benign gynecologic conditions, during the period January 2017 to December 2021. Results: There was an increase in the rate of performing minimally invasive hysterectomy procedures from 35 cases (12.5%) in 2017 to 85 cases (30.5%) in 2021. In addition, abnormal uterine bleeding was the most reported indication for minimally invasive hysterectomy (n = 84; 30.1%). Estimated blood loss was a significant predictor for both intraoperative complications (p < 0.001) and postoperative complications (p=0.004). Conclusion: Within the last five years, there has been an increasing trend of minimally invasive hysterectomy procedures at the OB-GYN department in KAMC, Saudi Arabia. And estimated blood loss is a significant predictor of intraoperative and postoperative complications of minimally invasive hysterectomy.
期刊介绍:
Obstetrics and Gynecology International is a peer-reviewed, Open Access journal that aims to provide a forum for scientists and clinical professionals working in obstetrics and gynecology. The journal publishes original research articles, review articles, and clinical studies related to obstetrics, maternal-fetal medicine, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine and infertility, reproductive endocrinology, and sexual medicine.